Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bronchiolitis Vaccines
Study findings from University of Edinburgh, Queen's Medical Research Institute provide new insights into bronchiolitis vaccines
November 5th, 2008
New research, 'Lung dendritic cells in respiratory syncytial virus bronchiolitis,' is the subject of a report. "Respiratory syncytial virus (RSV) bronchiolitis, an important respiratory disease in infancy, is thought to be caused by severe inflammation of the small peripheral airways and has been associated with the development of recurrent wheeze, childhood asthma, and early allergen sensitization. Both innate and adaptive immune responses are thought to contribute to the development of bronchiolitis in RSV infection," scientists writing in the The Pediatric Infectious Disease Journal report. "If vaccination and specific therapy for bronchiolitis, which are...
Source: Vaccine Weekly (2008-11-05)
|
